Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003

Article Abstract:

The 2003 outbreak of severe acute respiratory syndrome (SARS) in Beijing, China, lasted only two months because of various control measures that were introduced. These included setting up fever clinics, building a 1,000-bed SARS hospital, training all hospital workers in infection control procedures, closing universities, schools, libraries, bars, and theaters, isolating SARS patients in wards, quarantining all close personal contacts, and screening 14 million travelers. A total of 2,521 people were diagnosed with SARS and treated.

China, Beijing, China

---

Severe acute respiratory syndrome: providing care in the face of uncertainty

Article Abstract:

Health care workers should make every effort to adequately treat patients with SARS while protecting themselves as much as they can. As of June, 2003, many of the people who have been affected by SARS have been hospital personnel. It is not clear whether this happened because they did not take appropriate precautions or because the virus that causes SARS is easily transmitted.

Editorial

---

Interventions to increase influenza vaccination of health-care workers-California and Minnesota

Article Abstract:

The strategies implemented in the three clinical settings that increased the proportion of Health-Care Workers (HCWs) who received influenza vaccination are reported. The results demonstrate the value of making influenza vaccination convenient and free to HCWs.

California, Minnesota, Influenza vaccines, Influenza, Dosage and administration

Similar abstracts:

• Abstracts: SARS-associated coronavirus. The severe acute respiratory syndrome. Identification of a novel coronavirus in patients with severe acute respiratory syndrome
• Abstracts: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States
• Abstracts: Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses
• Abstracts: Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.